about
Indicators of quality use of medicines in South-East Asian countries: a systematic reviewStudy protocol for a cluster-randomised controlled trial of an NCD access to medicines initiative: evaluation of Novartis Access in Kenya.Challenges of medicines management in the public and private sector under Ghana's National Health Insurance Scheme - A qualitative study.Effects of the expansion of doctors' offices adjacent to private pharmacies in Mexico: secondary data analysis of a national survey.Factors influencing global antiretroviral procurement prices.Ambulatory health service users' experience of waiting time and expenditure and factors associated with the perception of low quality of care in MexicoComparison of medicines management strategies in insurance schemes in middle-income countries: four case studiesObstetric care and method of delivery in Mexico: results from the 2012 National Health and Nutrition Survey.Regulation of antibiotic sales in Mexico: an analysis of printed media coverage and stakeholder participation.Essential medicines for universal health coverage.Short report: Increasing access to treatment for Chagas disease: the case of Morelos, Mexico.Seasonal variation in penicillin use in Mexico and Brazil: analysis of the impact of over-the-counter restrictions.Impact of over-the-counter restrictions on antibiotic consumption in Brazil and Mexico.A research agenda to promote affordable and quality assured medicinesAccess to Medicines by Seguro Popular Beneficiaries: Pending Tasks towards Universal Health Coverage.Access to care for Chagas disease in the United States: a health systems analysisEvaluating the quality and use of economic data in decisions about essential medicines.Estimating the Burden of Chagas Disease in the United States.Health facility and skilled birth deliveries among poor women with Jamkesmas health insurance in Indonesia: a mixed-methods study.A new entity for the negotiation of public procurement prices for patented medicines in Mexico.Pharmaceutical policies in a crisis? Challenges and solutions identified at the PPRI ConferenceAccess to Medications for Cardiovascular Diseases in Low- and Middle-Income CountriesThe market dynamics of generic medicines in the private sector of 19 low and middle income countries between 2001 and 2011: a descriptive time series analysisUnit costs for delivery of antiretroviral treatment and prevention of mother-to-child transmission of HIV: a systematic review for low- and middle-income countries.Policies to promote use of generic medicines in low and middle income countries: a review of published literature, 2000-2010.Operational rules for the implementation of INN prescribing.[Clinics adjacent to private pharmacies in Mexico: infrastructure and characteristics of the physicians and their remuneration].International short-term medical missions: a systematic review of recommended practices.How Can Pricing and Reimbursement Policies Improve Affordable Access to Medicines? Lessons Learned from European Countries.Effects of over-the-counter sales restriction of antibiotics on substitution with medicines for symptoms relief of cold in Mexico and Brazil: time series analysis.Reforming antiretroviral price negotiations and public procurement: the Mexican experience.How much could be saved in Chinese hospitals in procurement of anti-hypertensives and anti-diabetics?Strategies and ethical considerations for the recruitment of young men who have sex with men: challenges of a vaccination trial in Mexico.Antenatal Care Among Poor Women in Mexico in the Context of Universal Health Coverage.Reply to "decrease in penicillin sales in Brazil after over-the-counter restrictions".Organizational elements of health service related to a reduction in maternal mortality: the cases of Chile and Colombia.Industry-Led Access-To-Medicines Initiatives In Low- And Middle-Income Countries: Strategies And Evidence.Use of antibacterial fixed-dose combinations in the private sector in eight Latin American Countries between 1999 and 2009.Access to medicines by ambulatory health service users in Mexico: an analysis of the national health surveys 1994 to 2006.Improving access to treatment for HIV in sub-Saharan Africa.
P50
Q26992029-C42D57B7-CE78-4C54-B6F6-D7F4CAF0E64BQ30379796-5FB9BF98-B357-4B31-B8CF-5EA7C71A5F76Q30385819-1B48E1BB-C517-456F-8013-5C3E28E0E50BQ30825750-EB887998-CC46-452F-B222-660DD5673D12Q30892581-AB397433-B9D8-4CD1-A351-E807DF5EF15FQ33614287-6A3D9A23-9C57-47BD-BDD9-9ADA00C6869CQ33697280-14DC565C-7950-4FF8-8BDC-6F6AE344ADD8Q34015558-E68986CD-246E-4525-BAC1-F68E9CCBCC5AQ34503017-9FDF4748-5F9C-44C8-964B-13194F6AD3E2Q34544415-5A03BCC0-DE7F-4B8A-9FE4-D64FAD7CE8A2Q34640131-4AA773D8-1940-4C8F-ABF5-B2F363D33381Q34921992-AD281D78-AE45-454B-B111-4B19939C3D00Q35022423-63D24CAC-7B27-4231-AC49-CC29F7FE1485Q35198451-D89F1923-7C19-451D-9A11-642F85604A16Q35788555-89B8117E-AA2B-4975-8DDC-3B5C31896923Q35836581-487959DD-81D1-4128-969F-D0237D1D4348Q35851002-9F09D7E3-C3F2-44DB-905A-0EFC02B36C8DQ36184364-56881DCF-3A05-42FE-B051-D92115CC2C12Q36266775-3D3B9977-7B53-459E-BA5C-0165DB54EEE0Q36316532-898DF301-34E2-4F20-8615-2F3158377CBFQ36687665-2D7507A5-08C3-4B64-B40A-199D2AA37D56Q36936076-F286987B-4D16-4A9D-B7CA-F580C8AB0E40Q37207470-1548DCB2-2FC9-4D0F-82AC-EFA156E81465Q37323399-3B51E00C-D586-4A10-B675-2B8C6A7C84A1Q38018411-A858660D-0775-44E8-970C-5E8695ADCBEDQ38156250-C670BEBF-51F2-4AFB-96A3-3B83D426363CQ38386620-987F229C-7F31-49C6-9C06-7F018874B8BDQ38945840-EE39CAB3-172C-4F12-8F32-574EF3BFDC70Q39072439-9FC7A071-4E96-46FC-A0CE-0802B358C646Q39172073-EA5E79C8-0227-4D3E-A39C-D2A59A16CB00Q39646766-956E0AE8-C381-4CE3-AE3E-C81EFCE007F2Q39834356-C42AC469-F200-4571-AA6F-8AE97C756B07Q39961168-6C73A337-A67D-4031-89E3-2994F1209747Q40817219-DD2D62AC-BD36-452F-943C-FEB6E1B82C32Q42546879-0A66530C-183C-4440-B87B-BD1BCB90B859Q43646304-5461971B-CD22-443F-9D96-7C8C84D22E91Q43741787-77A132BB-AEE6-495F-955C-D847D5AB182DQ43891080-9A2D8D9C-E6BD-4117-B3C9-D652AC5A4A68Q43902972-8CA688D1-4A55-4937-BC34-CB3A5B29639BQ43998708-88F817B6-4B01-42B1-8043-24E0EA5E4780
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Veronika J Wirtz
@ast
Veronika J Wirtz
@en
Veronika J Wirtz
@es
Veronika J Wirtz
@nl
Veronika J Wirtz
@sl
type
label
Veronika J Wirtz
@ast
Veronika J Wirtz
@en
Veronika J Wirtz
@es
Veronika J Wirtz
@nl
Veronika J Wirtz
@sl
prefLabel
Veronika J Wirtz
@ast
Veronika J Wirtz
@en
Veronika J Wirtz
@es
Veronika J Wirtz
@nl
Veronika J Wirtz
@sl
P106
P21
P31
P496
0000-0002-0863-8768